KindlyMD (NASDAQ:NAKA) Posts Quarterly Earnings Results, Misses Estimates By $0.91 EPS

KindlyMD (NASDAQ:NAKA) issued its earnings results on Thursday. The company reported ($1.40) EPS for the quarter, missing the consensus estimate of ($0.49) by ($0.91), Zacks reports. KindlyMD had a negative return on equity of 63.45% and a negative net margin of 1,067.93%.

KindlyMD Trading Down 7.4%

NASDAQ NAKA traded down $0.46 during trading hours on Thursday, reaching $5.79. The company’s stock had a trading volume of 144,618 shares, compared to its average volume of 197,276. The business has a 50-day simple moving average of $7.98 and a 200 day simple moving average of $7.62. KindlyMD has a 52 week low of $3.33 and a 52 week high of $26.00. The stock has a market cap of $106.22 million, a PE ratio of -0.16 and a beta of 16.03.

Analysts Set New Price Targets

Several research firms recently issued reports on NAKA. TD Cowen upped their price target on KindlyMD from $1.00 to $17.00 and gave the company a “buy” rating in a research report on Monday, July 27th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of KindlyMD in a report on Wednesday, November 4th. Finally, B. Riley Financial boosted their target price on shares of KindlyMD from $11.00 to $13.00 and gave the company a “buy” rating in a research note on Tuesday, September 22nd. Three equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, KindlyMD has an average rating of “Moderate Buy” and an average target price of $20.00.

Insider Activity at KindlyMD

In related news, CEO David F. Bailey bought 32,134 shares of the stock in a transaction dated Wednesday, August 19th. The stock was bought at an average cost of $5.59 per share, with a total value of $179,629.06. Following the completion of the acquisition, the chief executive officer owned 32,134 shares of the company’s stock, valued at $179,629.06. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders purchased 41,904 shares of company stock worth $235,231 over the last three months. 24.08% of the stock is currently owned by corporate insiders.

About KindlyMD

KindlyMD, Inc. is a healthcare company focused on providing integrated care for patients dealing with chronic pain, behavioral health conditions and substance-use disorders. The company emphasizes a patient-centered approach that combines medical treatment, behavioral health support and other services designed to address the underlying factors affecting a patient’s health and quality of life. KindlyMD’s services include chronic pain evaluation and management, medication-assisted treatment for opioid-use disorder, behavioral health care and related primary or supportive healthcare services.